Factory 99% Degarelix Powder CAS 214766-78-6 Anti-Cancer Chemical Intermediate Degarelix

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A673
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Degarelix
• CAS: 214766-78-6
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Anti-Cancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Degarelix
Appearance	White Powder
CAS NO.	214766-78-6
MF	C64H84F6N18O14S2
Storage	Keep in a cool, dry, dark location

 

Degarelix is a medication primarily used in the medical management of advanced prostate cancer. It acts as a gonadotropin-releasing hormone antagonist, blocking the action on its receptor in the pituitary gland.

 

1. Prostate Cancer Treatment: It is indicated for the treatment of advanced hormone-dependent prostate cancer, including metastatic and locally advanced disease.
2. Medical Therapy Combination: Often used in combination with other therapeutic agents, such as radiation therapy or surgery, to enhance treatment outcomes.
3. Long-term Hormonal Control: Prescribed for continuous administration to maintain suppression of levels.

1. Hormonal Suppression: By blocking receptors, Degarelix rapidly and profoundly suppresses the secretion of  LH and follicle-stimulating hormone (FSH) from the pituitary gland, leading to a reduction in production by the testes.
2. Tumor Growth Inhibition: By lowering levels, it helps inhibit the growth of prostate cancer cells that depend on androgen signaling for proliferation.
3. Symptom Management: Can improve symptoms related to prostate cancer, such as urinary obstruction, pain, and bone fractures, by reducing tumor size and slowing disease progression.